Recent Press Releases

Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates

08/11/16 - Dr. Karl Johe Resigns from Board of Directors; Company Announces Creation of Scientific Policy Committee with Dr. Johe as Chairman GERMANTOWN, Md., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceu... More

Neuralstem Announces NSI-189 Shows Enhancement of Long-Term Potentiation In Vitro

06/21/16 - Data Contribute to Understanding NSI-189 Mechanism of Action GERMANTOWN, Md., June 21, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system the... More

Neuralstem Announces New Chairman and Further Reorganization Plans

06/13/16 - GERMANTOWN, Md., June 13, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announc... More
More

Upcoming Events


There are currently no events scheduled.
More
Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
Share PageShare Page
E-mail AlertsE-mail Alerts
IR ContactsIR Contacts
Financial Tear SheetFinancial Tear Sheet